POLR2J Antibody

What is POLR2J and why is it important in cellular biology?

POLR2J is a 13.3 kDa subunit of RNA polymerase II, the enzyme complex responsible for transcribing DNA into RNA in eukaryotic cells. It plays a crucial role in the transcription of protein-coding genes, a process essential for gene expression and cellular function. POLR2J proteins are located in the nucleus, where they form part of the transcription machinery that interacts with promoter regions of genes, facilitating the recruitment of transcription factors and other regulatory elements . The proper functioning of POLR2J is vital, as disruption in its activity can lead to impaired transcription and has been associated with various diseases, including cancer .

What types of POLR2J antibodies are available for research?

Several types of POLR2J antibodies are available for research applications:

• Mouse monoclonal antibodies (e.g., POLR2J1/2/3 Antibody (G-2))

• Rabbit polyclonal antibodies (e.g., POLR2J Rabbit Polyclonal Antibody)

These antibodies are available in various formulations:

Many antibodies target different epitopes, with some specific to the N-terminal region while others target the C-terminal region of the protein .

What is the difference between POLR2J1, POLR2J2, and POLR2J3?

POLR2J1, POLR2J2, and POLR2J3 are paralogs (related genes resulting from gene duplication) that encode subunits of RNA polymerase II . While they share structural and functional similarities, they may have distinct roles in different cellular contexts or developmental stages. Some antibodies, such as the POLR2J1/2/3 Antibody (G-2), can detect all three forms in mouse, rat, and human samples , making them versatile for research across these species. Understanding the specific paralog being studied is important for precise experimental design and interpretation, particularly in research focused on gene regulation mechanisms .

What are the recommended applications for POLR2J antibodies?

POLR2J antibodies have been validated for multiple experimental applications:

When selecting an application, consider the experimental question, sample type, and specific antibody characteristics. For studying protein-protein interactions involving POLR2J, IP followed by Western blotting (co-IP) is recommended . For visualization of POLR2J in transcription factories or clusters, immunofluorescence with high-resolution microscopy provides valuable spatial information .

How should I optimize Western blotting protocols for POLR2J detection?

For optimal Western blotting results with POLR2J antibodies:

• Sample preparation: Use nuclear extracts since POLR2J is predominantly nuclear. Include protease inhibitors and phosphatase inhibitors if phosphorylation status is relevant.

• Gel selection: Use 12-15% polyacrylamide gels to properly resolve this small protein (13.3 kDa).

• Transfer conditions: For this small protein, use methanol-containing transfer buffer and shorter transfer times (60-90 minutes) or lower voltage.

• Blocking: 5% non-fat dry milk or BSA in TBST for 1 hour at room temperature.

• Primary antibody incubation: Dilute according to manufacturer recommendations (typically 1:500-1:2000) and incubate overnight at 4°C.

• Detection: Secondary antibodies conjugated to HRP can be used with enhanced chemiluminescence detection systems.

• Controls: Include positive controls (such as mouse skeletal muscle ) and negative controls (such as POLR2J-knockdown samples).

Troubleshooting tip: If background is high, increase washing steps and optimize blocking conditions. If signal is weak, extend exposure time or consider using a more sensitive detection system.

How can I use POLR2J antibodies to study RNA polymerase II clusters?

RNA polymerase II clusters, also known as transcription factories, can be studied using POLR2J antibodies through several advanced approaches:

• High-resolution microscopy: Techniques such as Structured Illumination Microscopy (SIM) can be used with fluorescently labeled antibodies against POLR2J to visualize cluster formation and morphology .

• Co-localization studies: Use POLR2J antibodies in combination with antibodies against other transcription-related proteins to study their spatial relationships within clusters.

• Live-cell imaging: For dynamic studies, fluorescently labeled antibody fragments (Fab) can be used to track POLR2J cluster formation and movement in living cells .

• Quantitative analysis: Image analysis software can be used to measure cluster size, intensity, morphology, and distribution. Research has shown that Pol II clusters display various morphologies that correlate with transcriptional states .

As described in the literature, "RNA Pol II clusters form in line with liquid phase wetting," and these structures represent dynamic entities that can be analyzed using sophisticated imaging and computational approaches . The antibodies allow visualization of different phosphorylation states of RNA Pol II (Ser2P and Ser5P), which correspond to different stages of transcription .

How can POLR2J antibodies be used to investigate transcriptional mechanisms in disease models?

POLR2J antibodies provide valuable tools for investigating transcriptional dysregulation in disease models, particularly cancer:

• Cancer research: Recent studies have shown that POLR2J expression promotes glioblastoma malignancy. Using POLR2J antibodies in immunoblotting and immunofluorescence experiments revealed that POLR2J is significantly overexpressed in GBM compared to normal tissues .

• Mechanistic studies: POLR2J antibodies can be used in co-immunoprecipitation assays to identify protein interaction partners. For example, researchers used POLR2J overexpression followed by co-IP to explore POLR2J's interaction with regulatory proteins in U251 glioblastoma cells .

• Functional analysis: In knockdown experiments, Western blotting with POLR2J antibodies can confirm successful protein reduction and monitor downstream effects on signaling pathways. Research has shown that "POLR2J knockdown significantly inhibited EGFR and AKT pathways involved in GBM cell proliferation" .

• Therapeutic response assessment: POLR2J antibodies can monitor changes in expression and activity following treatment with compounds like vorinostat, helping to understand mechanisms of therapeutic response in cancer models .

This approach has revealed that "POLR2J exhibits maximal upregulation in GBM compared to normal tissues across all cancer types" and "promotes cell proliferation, metastasis, and epithelial-mesenchymal transition (EMT) in GBM" .

How do I interpret conflicting POLR2J antibody results across different experimental systems?

When facing conflicting results using POLR2J antibodies across different experimental systems:

• Antibody specificity: Verify that the antibodies recognize the same epitope. Some antibodies target the N-terminus while others target the C-terminus of POLR2J . Additionally, some antibodies detect all three POLR2J paralogs (POLR2J1, POLR2J2, and POLR2J3) , while others may be specific to one form.

• Cell/tissue context: POLR2J expression and function can vary across cell types. For instance, POLR2J shows differential expression patterns in normal vs. cancer tissues, with particularly high expression in glioblastoma .

• Post-translational modifications: Consider that phosphorylation of RNA Pol II (including its subunits) changes during the transcription cycle and in response to cellular signals. Using phospho-specific antibodies may reveal different subpopulations of the protein .

• Experimental conditions: Different lysis buffers, fixation methods, or blocking agents can affect antibody binding. Standardize these factors when comparing across systems.

• Positive and negative controls: Include appropriate controls, such as POLR2J-overexpressing and knockdown samples, across all experimental systems.

• Cross-validation: Use multiple antibodies targeting different epitopes or employ alternative detection methods like mass spectrometry to validate findings.

As noted in research, "considering that the model is based on affinity differences due to Pol II phosphorylation, it is expected that inhibitors that perturb transcription by other pathways should not be captured by the model" , highlighting how modification states can affect experimental outcomes.

What is the role of POLR2J in biomolecular condensate formation?

POLR2J, as part of the RNA polymerase II complex, participates in the formation of biomolecular condensates that facilitate transcription:

Advanced imaging techniques combined with POLR2J antibodies have provided insights into how these biomolecular condensates form and function in transcriptional regulation.

What are common pitfalls when using POLR2J antibodies in immunofluorescence experiments?

When using POLR2J antibodies for immunofluorescence studies, researchers should be aware of these common pitfalls:

• Non-specific binding: POLR2J antibodies may bind to other RNA polymerase subunits due to structural similarities. Validate specificity through appropriate controls, including POLR2J knockdown samples.

• Fixation artifacts: Inappropriate fixation can alter nuclear architecture and POLR2J localization. Compare different fixation methods (PFA, methanol, etc.) to identify optimal conditions for preserving structure while maintaining epitope accessibility.

• Detection sensitivity: POLR2J is part of large multi-protein complexes, which may limit antibody accessibility. Signal amplification techniques (tyramide signal amplification, brightness-enhanced fluorophores) may be necessary for visualization of low-abundance protein forms.

• Phosphorylation-specific detection: As noted in research using "fluorescently labeled antibody fragments (Fab) specific against Ser2 and Ser5 phosphorylation (Pol II Ser2P, Pol II Ser5P)" , different phosphorylation states of RNA Pol II represent different functional states, requiring specific antibodies.

• Signal interpretation: When studying RNA Pol II clusters, "varied morphologies" may represent different functional states . Use quantitative image analysis to characterize these structures objectively.

• Background reduction: For improved signal-to-noise ratio, researchers have successfully used "local background subtraction" techniques for processing raw imaging data .

• Resolution limitations: Standard confocal microscopy may be insufficient to resolve individual clusters. Consider super-resolution techniques like SIM, STORM, or PALM for detailed structural analysis.

How can I validate the specificity of a POLR2J antibody in my experimental system?

To validate the specificity of a POLR2J antibody in your experimental system:

• Western blotting verification: Confirm the antibody detects a single band of the expected molecular weight (approximately 13 kDa) . Multiple bands may indicate cross-reactivity or post-translational modifications.

• Genetic manipulation: Use siRNA/shRNA knockdown or CRISPR-Cas9 knockout of POLR2J to demonstrate reduced or absent signal. This approach has been used in functional studies showing that "POLR2J silencing significantly triggered cell cycle G1/S phase arrest in GBM cells" .

• Overexpression validation: Overexpress tagged POLR2J and confirm co-localization with the antibody signal or detection of increased signal intensity.

• Peptide competition: Pre-incubate the antibody with the immunizing peptide before application to samples. Specific binding should be blocked by the peptide.

• Multiple antibodies: Use multiple antibodies targeting different epitopes of POLR2J to confirm consistent patterns.

• Mass spectrometry validation: Following immunoprecipitation with the POLR2J antibody, use mass spectrometry to confirm the identity of the captured proteins.

• Tissue/cell specificity: Verify that expression patterns match known POLR2J distribution. For example, POLR2J is highly expressed in certain cancers like glioblastoma compared to normal tissues .

• Cross-species reactivity: If the antibody claims reactivity across species (e.g., "reactivity with human, mouse, and rat samples" ), validate this by testing samples from each species.

What are best practices for co-immunoprecipitation studies using POLR2J antibodies?

For successful co-immunoprecipitation (Co-IP) studies using POLR2J antibodies:

• Lysis buffer optimization: Use gentle lysis conditions that preserve protein-protein interactions. A detailed protocol from research includes: "U251 cells transfected with POLR2J overexpressed plasmid for 48 h were lysed with IP buffer and centrifugation at 120,000 rpm for 30 min at 4°C" .

• Pre-clearing: Pre-clear lysates with protein A/G beads to reduce non-specific binding.

• Antibody selection: Choose high-affinity antibodies validated for IP applications. The POLR2J1/2/3 Antibody (G-2) has been validated for immunoprecipitation .

• Controls: Always include:

  • Negative control with isotype-matched IgG: "cell lysates were divided equally hybridized with 20 µl mouse IgG magnetic beads and anti-Flag Immunomagnetic beads"

  • Input sample (typically 5-10% of the lysate used for IP)

  • Positive control with a known interacting partner

• Washing stringency: Balance between removing non-specific interactions and preserving specific ones. A published protocol describes: "add 500 µl of PBST (NaCl 136.89 mM, KCl 2.67 mM, Na₂HPO₄ 8.1 mM, KH₂PO₄ 1.76 mM, 0.5% Tween 20) to the above precipitate, and redispersed the beads by gently blowing, then flip the sample up and down for 5 min and removed the supernatant after magnetic separation and repeated the above steps 3 times" .

• Detection method: Use sensitive detection methods for Western blotting of immunoprecipitated complexes, especially for detecting transient or weak interactions.

• Reciprocal Co-IP: When possible, perform reciprocal Co-IPs by immunoprecipitating with antibodies against the interacting partner and blotting for POLR2J.

• Crosslinking consideration: For transient interactions, consider using crosslinking agents before lysis.

• Mass spectrometry analysis: For unbiased identification of novel interaction partners, consider coupling Co-IP with mass spectrometry analysis.

By following these guidelines, researchers can obtain reliable results from Co-IP experiments using POLR2J antibodies to understand the protein's interactions within the transcriptional machinery and beyond.